Revolution Medicines Built a $4.3 Billion Wall Around Daraxonrasib
Witfire Elite Oncology Strategy Case Studies Financing Long Read Pharma Market Case Studies Witfire Elite View Revolution Medicines Built a $4.3 Billion Wall Around…
Witfire Coverage
Category: Pharma News
Moderna Flu Vaccine Reversal: FDA Refused to Review It—Then Advisers Voted 9-0 Twice
Witfire Elite FDA & Regulatory Case Studies Strategy Long Read Pharma Market Case Studies Witfire Elite View Moderna Flu Vaccine Reversal FDA Refused to…
GSK Bought September and November 2026: The $10.6 Billion Nuvalent Autopsy
Witfire Elite Oncology M&A Case Studies Strategy Long Read Pharma Market Case Studies Witfire Elite View GSK Did Not Simply Buy Nuvalent It Bought…
India CRO Boom: Why India’s Next CRO Boom May Be Built on Molecules It Did Not Invent
Witfire Elite Pharma Markets Case Studies Strategy Long Read Pharma Market Case Studies Witfire Elite View India CRO Boom Why Chinese Molecules May Build…
Iran War Pharma Shock: Why India’s API Dependence Hurts More Than China’s Biotech Lead
Witfire Elite Pharma Markets Case Studies Strategy Long Read Pharma Market Case Studies Witfire Elite View Iran War Pharma Shock Why India’s API Dependence…
CagriSema May Not Be Enough to Restore Novo Nordisk’s Obesity Lead
Novo Nordisk did not lose momentum because CagriSema is a weak drug. That is too simple. The sharper problem is that CagriSema is being…
India’s Generic Ozempic Boom Is a Margin Trap—and the Price Collapse It Started Has Now Reached the US
Witfire Elite View · Pharma Market Case Study · Updated 12 June 2026 The cheapest semaglutide in the world is made in India —…
FTX-6058 and Pociredir: FDA’s PRC2 Risk View Hit a Promising Sickle Cell Drug
Witfire Elite FDA & Regulatory Case Studies Strategy Breaking Case Study FDA & Regulatory Intelligence Witfire Elite View FTX-6058 and Pociredir FDA’s PRC2 Risk…
IQVIA Wegovy Pill Data and Oral GLP-1 Market Expansion
Witfire Elite Pharma Markets Case Studies Strategy Long Read Pharma Market Case Studies Witfire Elite View IQVIA Wegovy Pill Data Oral GLP-1 May Bring…
Fulcrum’s Pociredir Collapse: How FDA’s PRC2 Risk View Crushed a Data-Rich Sickle Cell Drug
Witfire Elite FDA & Regulatory Case Studies Strategy Breaking Case Study FDA & Regulatory Intelligence Witfire Elite View Fulcrum’s Pociredir Collapse How FDA’s PRC2…